DnB Asset Management AS Reduces Stock Position in Danaher Corporation $DHR

Key Points

• DnB Asset Management AS reduced its stake in Danaher Corporation by 1.0% to 172,763 shares, valued at $35.4 million as per their recent SEC filing.
• Danaher reported $1.80 EPS for the last quarter, beating expectations of $1.64, with revenue of $5.94 billion reflecting a 3.4% year-over-year increase.
• Analyst ratings indicate strong confidence, with a consensus rating of "Moderate Buy" and an average price target of $246.35 based on input from seventeen analysts.

DnB Asset Management AS cut its position in Danaher Corporation (NYSE:DHR - Free Report) by 1.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 172,763 shares of the conglomerate's stock after selling 1,704 shares during the period. DnB Asset Management AS's holdings in Danaher were worth $35,416,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. GHP Investment Advisors Inc. increased its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares in the last quarter. Heck Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth about $27,000. Sierra Ocean LLC grew its position in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in Danaher during the 1st quarter valued at approximately $31,000. Finally, Dunhill Financial LLC raised its stake in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares of the company's stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 11.20% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have weighed in on DHR. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. UBS Group lowered their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a report on Wednesday, July 23rd. Wells Fargo & Company cut their target price on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Guggenheim reiterated a "buy" rating and issued a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Barclays reissued an "overweight" rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $246.35.

Danaher Price Performance

Shares of NYSE DHR traded down $4.39 during mid-day trading on Tuesday, hitting $194.24. 3,344,624 shares of the company's stock traded hands, compared to its average volume of 4,138,020. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The company's 50-day moving average is $201.95 and its two-hundred day moving average is $199.23. The company has a market capitalization of $139.09 billion, a P/E ratio of 41.33, a PEG ratio of 2.79 and a beta of 0.75.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. During the same quarter in the previous year, the business earned $1.72 EPS. The company's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.